UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota Journal article
Li, Chenwen, Zhao, Yang, Cheng, Juan, Guo, Jiawei, Zhang, Qixiong, Zhang, Xiangjun, Ren, Jiong, Wang, Fengchao, Huang, Jun, Hu, Houyuan, Wang, Ruibing, Zhang, Jianxiang. A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota[J]. Advanced Science, 2019, 6(18).
Authors:  Li, Chenwen;  Zhao, Yang;  Cheng, Juan;  Guo, Jiawei;  Zhang, Qixiong; et al.
Favorite | TC[WOS]:137 TC[Scopus]:142  IF:14.3/16.3 | Submit date:2020/04/02
Colitis Targeting  Gut Microbiota  Nanotherapy  Proresolving Peptide  Reactive Oxygen Species  
Facile Assembly of Cost-Effective and Locally Applicable or Injectable Nanohemostats for Hemorrhage Control Journal article
Juan Cheng, Shibin Feng, Songling Han, Xiangjun Zhang, Yidan Chen, Xing Zhou, Ruibing Wang, Xiaohui Li, Houyuan Hu, Jianxiang Zhang. Facile Assembly of Cost-Effective and Locally Applicable or Injectable Nanohemostats for Hemorrhage Control[J]. ACS Nano, 2016, 10(11), 9957-9973.
Authors:  Juan Cheng;  Shibin Feng;  Songling Han;  Xiangjun Zhang;  Yidan Chen; et al.
Favorite | TC[WOS]:44 TC[Scopus]:43  IF:15.8/16.2 | Submit date:2018/11/06
Cholic Acid  Hemostasis  Nanohemostat  Nanoparticle  Polyethylenimine  Self-assembly  
A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease Journal article
Qixiong Zhang, Hui Tao, Yongyao Lin, Ying Hu, Huijie An, Dinglin Zhang, Shibin Feng, Houyuan Hu, Ruibing Wang, Xiaohui Li, Jianxiang Zhang. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease[J]. Biomaterials, 2016, 105, 206-221.
Authors:  Qixiong Zhang;  Hui Tao;  Yongyao Lin;  Ying Hu;  Huijie An; et al.
Favorite | TC[WOS]:179 TC[Scopus]:184  IF:12.8/13.1 | Submit date:2018/11/06
Colitis  Cyclodextrin  Drug Delivery  Reactive Oxygen Species  Responsive Nanoparticles  Targeted Therapy